Wang, P., Qin, H., Han, Z., Guo, J., Yu, J., Ma, L., Lu, L., Zhang, H., Liu, Y., Deng, J., Liu, Y. (2025). Evaluating the safety and efficacy of CRISPR/AaCas12b
            <sup>Max</sup>
            -modified tumor infiltrating lymphocytes (GT300) as monotherapy in advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5613